Overview
2015Founded1
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2019
-670.5%Operating margin4
-626.4%Net margin4
40.0%Revenue growth, 20194
-104.0%Return on equity5
-$44.8MFree cash flow4
Where the money goes
Where each dollar of revenue went, fiscal 2019
- Research and development98¢$40.2M
- Income tax2¢$677.0K
Out of $7.0M in revenue.4 The company lost money this year.
Financial statements
No quarterly figures reported.
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Cash | $26.3M7 | $55.1M7 | $49.4M6 | $16.0M4 |
| Current assets | $56.3M7 | $88.8M6 | $49.0M4 | |
| Total assets | $58.8M7 | $89.3M6 | $51.0M4 | |
| Current liabilities | $9.8M7 | $6.2M6 | $7.6M4 | |
| Total liabilities | $9.9M7 | $6.4M6 | $8.9M4 | |
| Shareholders’ equity | -$26.3M7 | -$55.8M6 | $82.9M4 | $42.2M5 |
| Shares outstanding | 12.6K shares7 | 13.1M shares6 | 13.3M shares4 |
Former names
- Entasis Therapeutics LtdDec 8, 2017 to Aug 17, 20183
Timeline
- 2015Founded Founded1
Recent filings
- Jul 13, 20224
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20224 OWNERSHIP DOCUMENT
- Jul 11, 20228-K
- May 23, 20228-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- WikidataQ100956344
- SEC EDGARCIK 1724344
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataEntasis Therapeutics on Wikidata
- 2
- 3
- 4
- 5
- 6
- 7